Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 7, 2011, Pages 1505-1514

  Deschepper, M ^a   Oudina, K ^a   David, B ^a,b   Myrtil, V ^a   Collet, C ^c   Bensidhoum, M ^a   Logeart Avramoglou, D ^a   Petite, H ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Central School of Paris   (France)

^c Laribolslere Hospital   (France)

Author keywords

Bone; Glucose; Hypoxia; Ischemia; Marrow stromal cells; Mesenchymal stem cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID; OXYGEN; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; CELL CULTURE; CELL HYPOXIA; CELL SURVIVAL; CYTOLOGY; ISCHEMIA; MESENCHYMAL STEM CELL; METABOLISM; PHYSIOLOGY; SHEEP; TISSUE ENGINEERING;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; GLUCOSE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; LACTIC ACID; MESENCHYMAL STEM CELLS; OXYGEN; SHEEP; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

OVIS ARIES;

EID: 79959486657     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01138.x     Document Type: Article

References (41)

1. Logeart-Avramoglou D, Anagnostou F, Bizios R, et al Engineering bone: challenges and obstacles. J Cell Mol Med. 2005; 9: 72-84.
2. Quarto R, Mastrogiacomo M, Cancedda R, et al Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med. 2001; 344: 385-6.
3. Ohgushi H, Kotobuki N, Funaoka H, et al Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials. 2005; 26: 4654-61.
4. Kitoh H, Kitakoji T, Tsuchiya H, et al Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-a preliminary result of three cases. Bone. 2004; 35: 892-8.
5. Vacanti CA, Bonassar LJ, Vacanti MP, et al Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med. 2001; 344: 1511-4.
6. Viateau V, Guillemin G, Bousson V, et al Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. J Orthop Res. 2007; 25: 741-9.
7. Petite H, Viateau V, Bensaid W, et al Tissue-engineered bone regeneration. Nat Biotechnol. 2000; 18: 959-63.
8. Mastrogiacomo M, Corsi A, Francioso E, et al Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate. Tissue Eng. 2006; 12: 1261-73.
9. Bruder SP, Kraus KH, Goldberg VM, et al The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am. 1998; 80: 985-96.
10. Bensaid W, Oudina K, Viateau V, et al De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. Tissue Eng. 2005; 11: 814-24.
11. Logeart-Avramoglou D, Oudina K, Bourguignon M, et al In vitro and in vivo bioluminescent quantification of viable stem cells in engineered constructs. Tissue Eng C Methods. 2009.
12. Degano IR, Vilalta M, Bago JR, et al Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials. 2008; 29: 427-37.
13. Haider H, Ashraf M. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol. 2008; 45: 554-66.
14. Togel F, Yang Y, Zhang P, et al Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol. 2008; 295: F315-21.
15. Colton CK. Implantable biohybrid artificial organs. Cell Transplant. 1995; 4: 415-36.
16. Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J Exp Med. 1973; 138: 745-53.
17. Sutherland RM, Sordat B, Bamat J, et al Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. Cancer Res. 1986; 46: 5320-9.
18. Brighton CT, Krebs AG. Oxygen tension of healing fractures in the rabbit. J Bone Joint Surg Am. 1972; 54: 323-32.
19. Heppenstall RB, Grislis G, Hunt TK. Tissue gas tensions and oxygen consumption in healing bone defects. Clin Orthop Relat Res. 1975: 357-65.
20. Epari DR, Lienau J, Schell H, et al Pressure, oxygen tension and temperature in the periosteal callus during bone healing-an in vivo study in sheep. Bone. 2008; 43: 734-9.
21. Guillemin G, Patat JL, Fournie J, et al The use of coral as a bone graft substitute. J Biomed Mater Res. 1987; 21: 557-67.
22. Schop D, Janssen FW, van Rijn LD, et al Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng A. 2009; 15: 1877-86.
23. Piersanti S, Sacchetti B, Funari A, et al Lentiviral transduction of human postnatal skeletal (stromal, mesenchymal) stem cells: in vivo transplantation and gene silencing. Calcif Tissue Int. 2006; 78: 372-84.
24. Bensaid W, Triffitt JT, Blanchat C, et al A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials. 2003; 24: 2497-502.
25. Ferrari A, Hannouche D, Oudina K, et al In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye. J Biomed Mater Res. 2001; 56: 361-7.
26. Pettersen EO, Larsen LH, Ramsing NB, et al Pericellular oxygen depletion during ordinary tissue culturing, measured with oxygen microsensors. Cell Prolif. 2005; 38: 257-67.
27. Metzen E, Wolff M, Fandrey J, et al Pericellular PO2 and O2 consumption in monolayer cell cultures. Respir Physiol. 1995; 100: 101-6.
28. Allen CB, Schneider BK, White CW. Limitations to oxygen diffusion and equilibration in in vitro cell exposure systems in hyperoxia and hypoxia. Am J Physiol Lung Cell Mol Physiol. 2001; 281: L1021-7.
29. Chapman JD, Sturrock J, Boag JW, et al Factors affecting the oxygen tension around cells growing in plastic Petri dishes. Int J Radiat Biol Relat Stud Phys Chem Med. 1970; 17: 305-28.
30. Rosenberger C, Griethe W, Gruber G, et al Cellular responses to hypoxia after renal segmental infarction. Kidney Int. 2003; 64: 874-86.
31. Grayson WL, Zhao F, Izadpanah R, et al Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol. 2006; 207: 331-9.
32. Chen J, Baydoun AR, Xu R, et al Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Stem Cells. 2008; 26: 135-45.
33. Gui C, Wang JA, He AN, et al Heregulin protects mesenchymal stem cells from serum deprivation and hypoxia-induced apoptosis. Mol Cell Biochem. 2007; 305: 171-8.
34. Zhu W, Chen J, Cong X, et al Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells. 2006; 24: 416-25.
35. Mylotte LA, Duffy AM, Murphy M, et al Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells. 2008; 26: 1325-36.
36. Kruyt MC, de Bruijn JD, Wilson CE, et al Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. Tissue Eng. 2003; 9: 327-36.
37. Ma T, Grayson WL, Frohlich M, et al Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol Prog. 2009; 25: 32-42.
38. Li YM, Schilling T, Benisch P, et al Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun. 2007; 363: 209-15.
39. Vordermark D, Kraft P, Katzer A, et al Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Cancer Lett. 2005; 230: 122-33.
40. Russ AL, Haberstroh KM, Rundell AE. Experimental strategies to improve in vitro models of renal ischemia. Exp Mol Pathol. 2007; 83: 143-59.
41. Deschepper M, Bensidhoum M, Logeart-Avramoglou D, et al Glucose supply, but not long-term exposure to continuous hypoxia, affect mesenchymal stem cells (MSCs) function. Poster presentation at TERMIS World Congress. Seoul, 2009.